National Center for Complementary and Alternative Medicine; Notice of Meeting, 35196-35197 [E9-17204]
Download as PDF
<![CDATA[
35196
Federal Register / Vol. 74, No. 137 / Monday, July 20, 2009 / Notices
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Dr.
Linda Kupfer, Fogarty International
Center, National Institutes of Health, 16
Center Drive, Building 16, Bethesda, MD
20892–6705 or call non-toll-free number
301–496–3288 or e-mail your request,
including your address to
kupferl@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
Dated: July 13, 2009.
Timothy J. Tosten,
Executive Officer, Fogarty International
Center, National Institutes of Health.
[FR Doc. E9–17214 Filed 7–17–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0544]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Record Retention Requirements for the
Soy Protein and Coronary Heart
Disease Health Claim
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Record Retention Requirements for the
Soy Protein and Coronary Heart Disease
Health Claim’’ has been approved by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Information
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–796–3794.
SUPPLEMENTARY INFORMATION: In the
Federal Register of January 14, 2009 (74
FR 2079), the agency announced that
erowe on DSK5CLS3C1PROD with NOTICES
SUMMARY:
VerDate Nov<24>2008
15:18 Jul 17, 2009
Jkt 217001
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0428. The
approval expires on May 31, 2012. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
Dated: July 10, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–17094 Filed 7–17–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Review Predoctoral
and Postdoctoral Fellowship Applications.
Date: July 28, 2009.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Peter Kozel, PhD,
Scientific Review Officer, NCCAM, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892–5475. 301–496–8004.
kozelp@mail.nih.gov.
This notice is being published less than 15
days prior to meeting due to scheduling
conflicts.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: July 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17202 Filed 7–17–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the National Advisory
Council for Complementary and
Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussion could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: September 11, 2009.
Closed: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Open: 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director
of the National Center for Complementary
and Alternative Medicine, presentation of a
new research initiative, and other business of
the Council.
Place: National Institutes of Health,
Neuroscience Building, 6001 Executive
Boulevard, Conference Rooms C & D,
Bethesda, MD 20892.
Contact Person: Martin H. Goldrosen, PhD.,
Executive Secretary, Director, Division of
Extramural Activities, National Center for
Complementary and Alternative Medicine,
E:\FR\FM\20JYN1.SGM
20JYN1
Federal Register / Vol. 74, No. 137 / Monday, July 20, 2009 / Notices
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892. (301) 594–2014.
The public comments session is scheduled
from 3:30–4 p.m., but could change
depending on the actual time spent on each
agenda item. Each speaker will be permitted
5 minutes for their presentation. Interested
individuals and representatives of
organizations are requested to notify Dr.
Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Boulevard, Suite 401,
Bethesda, Maryland, 20892, 301–594–2014,
Fax: 301–480–9970. Letters of intent to
present comments, along with a brief
description of the organization represented,
should be received no later than 5 p.m. on
September 7, 2009. Only one representative
of an organization may present oral
comments. Any person attending the meeting
who does not request an opportunity to speak
in advance of the meeting may be considered
for oral presentation, if time permits, and at
the discretion of the Chairperson. In
addition, written comments may be
submitted to Dr. Martin H. Goldrosen at the
address listed above up to ten calendar days
(September 21, 2009) following the meeting.
Copies of the meeting agenda and the
roster of members will be furnished upon
request by contacting Dr. Martin H.
Goldrosen, Executive Secretary, NACCAM,
National Center for Complementary and
Alternative Medicine, National Institutes of
Health, 6707 Democracy Boulevard, Suite
401, Bethesda, Maryland 20892, 301–594–
2014, Fax 301–480–9970, or via e-mail at
naccames@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.701, ARRA Related
Biomedical Research and Research Support
Awards.; 93.213, Research and Training in
Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: July 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17204 Filed 7–17–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
erowe on DSK5CLS3C1PROD with NOTICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
VerDate Nov<24>2008
15:18 Jul 17, 2009
Jkt 217001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel. ARRA Grant
Opportunities (RC2) in CAM.
Date: August 5, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Martina Schmidt, PhD,
Scientific Review Officer, Office of Scientific
Review, National Center for Complementary
& Alternative Medicine, NIH, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, 301–594–3456,
schmidma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.701, ARRA Related
Biomedical Research and Research Support
Awards; 93.213, Research and Training in
Complementary and Alternative Medicine,
National Institutes of Health, HHS)
35197
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Cardiac Translational Research
Implementation Program.
Date: July 24, 2009.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Youngsuk Oh, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7182,
Bethesda, MD 20892–7924, 301–435–0277,
yoh@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17206 Filed 7–17–09; 8:45 am]
BILLING CODE 4140–01–P
Dated: July 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17205 Filed 7–17–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Cancer Institute; Cancellation
of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice is hereby given of the
cancellation of the National Cancer
Institute Special Emphasis Panel,
August 5, 2009, 8 a.m. to August 6,
2009, 5 p.m., Marriott Bethesda North
Hotel & Conference Center, Bethesda,
MD which was published in the Federal
Register on June 26, 2009, 74FR30592.
This notice is to cancel the NCI–
ARRA Grand Opportunities-Clinical/
Translational Special Emphasis Panel
that was to be held on August 5–6, 2009.
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
National Institutes of Health
Dated: July 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–17207 Filed 7–17–09; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\20JYN1.SGM
20JYN1
]]>Agencies
[Federal Register Volume 74, Number 137 (Monday, July 20, 2009)]
[Notices]
[Pages 35196-35197]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-17204]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary and Alternative Medicine;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the National
Advisory Council for Complementary and Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and/or contract
proposals and the discussion could disclose confidential trade secrets
or commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: September 11, 2009.
Closed: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Open: 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director of the National Center
for Complementary and Alternative Medicine, presentation of a new
research initiative, and other business of the Council.
Place: National Institutes of Health, Neuroscience Building,
6001 Executive Boulevard, Conference Rooms C & D, Bethesda, MD
20892.
Contact Person: Martin H. Goldrosen, PhD., Executive Secretary,
Director, Division of Extramural Activities, National Center for
Complementary and Alternative Medicine,
[[Page 35197]]
National Institutes of Health, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892. (301) 594-2014.
The public comments session is scheduled from 3:30-4 p.m., but
could change depending on the actual time spent on each agenda item.
Each speaker will be permitted 5 minutes for their presentation.
Interested individuals and representatives of organizations are
requested to notify Dr. Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland, 20892, 301-594-2014, Fax:
301-480-9970. Letters of intent to present comments, along with a
brief description of the organization represented, should be
received no later than 5 p.m. on September 7, 2009. Only one
representative of an organization may present oral comments. Any
person attending the meeting who does not request an opportunity to
speak in advance of the meeting may be considered for oral
presentation, if time permits, and at the discretion of the
Chairperson. In addition, written comments may be submitted to Dr.
Martin H. Goldrosen at the address listed above up to ten calendar
days (September 21, 2009) following the meeting.
Copies of the meeting agenda and the roster of members will be
furnished upon request by contacting Dr. Martin H. Goldrosen,
Executive Secretary, NACCAM, National Center for Complementary and
Alternative Medicine, National Institutes of Health, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax
301-480-9970, or via e-mail at naccames@mail.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign-in at the security desk upon entering the
building.
(Catalogue of Federal Domestic Assistance Program Nos. 93.701, ARRA
Related Biomedical Research and Research Support Awards.; 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: July 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-17204 Filed 7-17-09; 8:45 am]
BILLING CODE 4140-01-P
